ZNF25 Pan-Cancer Analysis: Biomarker and Immunotherapy Target Exploration

A 2026 research document by Xiaohong Yi presents a systematic pan-cancer analysis of the ZNF25 gene. The study integrates data from TCGA, GTEx, and other platforms to evaluate ZNF25's diagnostic and prognostic potential, immune infiltration associations, and functional role in glioma progression. The 1.6 MB document includes results from bioinformatics analyses and experimental validation in cell lines.

Use Cases

• Identifying potential pan-cancer diagnostic biomarkers based on ZNF25 expression patterns.
• Investigating associations between gene expression and immune cell infiltration across cancer types.
• Exploring molecular mechanisms of glioma progression linked to the PI3K-AKT pathway.
• Validating bioinformatics findings with in vitro functional assays like cell viability and migration.

Strengths

• Analysis integrates data from multiple authoritative sources including TCGA and GTEx.
• Functional validation includes siRNA knockdown and RNA-seq in glioma cell lines.
• Document is licensed under CC-BY-4.0 for open reuse.

Limitations

• The primary data file is a 1.6 MB DOCX document; underlying raw datasets are not directly provided.
• Row and column counts for any integrated datasets are unknown.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Analysis based on TCGA, GTEx, cBioPortal, TISIDB, TIMER, and Sangerbox platforms.

Collection Method

Systematic pan-cancer bioinformatics analysis combined with experimental validation (siRNA, RNA-seq) in cell lines.

Freshness

Last updated 2026-06-02 04:28:28; freshness should be verified.